The invention relates to the use of lactic acid-producing bacteria to boost the immune system.
대표청구항▼
1. A composition comprising inactivated or dead Bacillus coagulans bacteria, said inactivated or dead Bacillus coagulans bacteria being present in an immune system boosting amount, wherein said inactivated or dead Bacillus coagulans bacteria comprise inactivated or dead Bacillus coagulans spores. 2.
1. A composition comprising inactivated or dead Bacillus coagulans bacteria, said inactivated or dead Bacillus coagulans bacteria being present in an immune system boosting amount, wherein said inactivated or dead Bacillus coagulans bacteria comprise inactivated or dead Bacillus coagulans spores. 2. The composition of claim 1, which is in the form of a powder. 3. The composition of claim 1, wherein said inactivated or dead Bacillus coagulans bacteria are purified. 4. The composition of claim 3, wherein said purified inactivated or dead Bacillus coagulans bacteria are dried or lyophilized. 5. The composition of claim 1, which is the form of a pill, capsule, or suspension. 6. The composition of claim 1, which is in the form of a beverage composition. 7. The composition of claim 1, which is in the form of a food composition. 8. The composition of claim 1, wherein said inactivated or-dead Bacillus coagulans bacteria are on the surface of said composition. 9. The composition of claim 1, further comprising trehalose, malto-dextrin, rice flour, micro-crystalline cellulose (MCC) magnesium stearate, inositol, a fructo-oligosaccharide (FOS), or a gluco-oligosaccharide (GOS). 10. The composition of claim 1, further comprising dextrose or sucrose. 11. The composition of claim 1, further comprising an antioxidant, a buffering agent, a coloring agent, or a flavoring. 12. The composition of claim 1, further comprising a vitamin or a mineral. 13. The composition of claim 1, further comprising a thickening agent. 14. The composition of claim 13, wherein the thickening agent comprises polyvinylpyrrolidone, polyethylene glycol, or carboxymethylcellulose. 15. The composition of claim 1, wherein said composition comprises purified dried or lyophilized dead Bacillus coagulans bacteria that have been reconstituted in water or other aqueous solution. 16. The composition of claim 1, comprising dead Bacillus coagulans bacteria, wherein said dead Bacillus coagulans bacteria are heat killed Bacillus coagulans bacteria. 17. The composition of claim 1, wherein said immune system boosting amount comprises about 0.1 mg to about 10 grams. 18. The composition of claim 1, wherein said immune system boosting amount comprises about 1 mg to about 10 grams. 19. The composition of claim 1, wherein said immune system boosting amount comprises about 10 mg to about 5 grams. 20. The composition of claim 1, wherein said immune system boosting amount comprises about 100 mg to about 1 gram. 21. The composition of claim 1, wherein said immune system boosting amount comprises about 200 mg to about 1 gram. 22. The composition of claim 1, wherein said inactivated or dead Bacillus coagulans bacteria comprise inactivated or dead Bacillus coagulans vegetative cells. 23. The composition of claim 1, further comprising a supernatant of Bacillus coagulans. 24. The composition of claim 23, wherein said supernatant is dried supernatant. 25. The composition of claim 1, wherein said Bacillus coagulans comprises Bacillus coagulans hammer strain Accession No. ATCC 31284. 26. The composition of claim 1, wherein said Bacillus coagulans comprises a strain derived from Bacillus coagulans hammer strain Accession No. ATCC 31284. 27. The composition of claim 1, wherein said Bacillus coagulans comprises GBI-30 strain (ATCC Designation Number PTA-6086), GBI-20 strain (ATCC Designation Number PTA-6085), or GBI-40 strain (ATCC Designation Number PTA-6087).
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (81)
Farmer,Sean; Lefkowitz,Andrew R., Absorbent product containing absorbent structure and bacillus coagulans.
Armau Elise (Toulouse FRX) Drocourt Daniel (Toulouse FRX) Etienne Gilles (Toulouse FRX) Tiraby Grard (Toulouse FRX), Application of antibiotics of the phleomycin family as selection agent in the field of genetic engineering.
Neyra Carlos A. (Kendall Park NJ) Sadasivan Lakshmi (Piscataway NJ), Bacillus licheniformis producing antifungal agents and uses thereof for control of phytopathogenic fungi.
Bailly Jean-Claude (Martigues FRX) Bres Philippe (Fos-Sur-Mer FRX) Chabrand Christine (Martigues FRX) Daire Erick (Chateauneuf-Les-Martigues FRX), Catalyst and prepolymer used for the preparation of polyolefins.
Moreno Bondi IT; Paola Messi IT; Giuliano Frigerio IT; Danila Ingrid Marchioretto IT; Valter Gatti IT, Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora.
Delespaul Gilbert (Vendome FRX) Dhoms Philippe (Vendome FRX) Raibaud Pierre (Jouy-en-Josas FRX) Szylit Odette (Igny FRX), Food additive intended for human consumption and as animal feed and foodstuffs containing it.
St. Pierre Leon E. (Frelighsburg CAX) Brown George R. (Dollard-Des-Ormeaux CAX) Tan Zhanjie (Toronto CAX) Clas Sophie-Dorothee (Town of Mount Royal CAX), Ingestible polymeric phosphonium salts, composition thereof and method of treating hypercholesterolemia.
Randall, Bruce W.; Taylor, James H.; Ely, Mark N.; Oetzel, Kenneth G., Methods and systems for use in maintaining media data quality upon conversion to a different data format.
Farmer, Sean; Lefkowitz, Andrew R., Methods for inhibiting microbial infections associated with sanitary products and for enhancing sanitary product degradation.
Panigrahi Pinaki ; Gewolb Ira H. ; Morris ; Jr. J. Glenn, Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof.
Kong Huimin (Beverly MA) Schildkraut Ira (Hamilton MA), Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same.
Reddy Malireddy S. (6983 S. Telluride St. Aurora CO 80016), Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconos.
Khorkova Evgenia A. (ulitsa Generala Glagoleva ; d. 25 ; korpus 2 ; kv.26 Moscow SUX) Semenikhina Vera F. (ulitsa Ostrovityanova d. 24 ; korpus 1 ; kv. 13 Moscow SUX) Ivanova Lilia N. (ulitsa Khadyns, Sour milk product.
Borody Thomas J. (144 Great North Road Five Dock ; New South Wales 2046 AUX), Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.